Clinical Study
Antiviral Treatment Alters the Frequency of Activating and Inhibitory Receptor-Expressing Natural Killer Cells in Chronic Hepatitis B Virus Infected Patients
Table 2
Virological outcomes to tenofovir or adefovir.
| |||||||||||||||||||||||||||
Compare with the initial of the treatment, *P < 0.05; compare with two drugs, #P < 0.05. |